Epidoxorubicin vs idarubicin containing regimens in intermediate and high grade non-Hodgkin's lymphoma: Preliminary results of a multicentric randomized trial

M. Brugiatelli, M. Federico, P. G. Gobbi, P. Avanzini, V. Callea, L. Cavanna, A. De Pasquale, A. U. Di Prisco, N. Di Rienzo, V. Silingardi, C. Mauri

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)306-312
Number of pages7
Issue number5
Publication statusPublished - 1993


  • chemotherapy
  • dose intesity
  • epidoxorubicin
  • idarubicin
  • non Hodgkin's lymphoma
  • randomized trial
  • toxicity

ASJC Scopus subject areas

  • Hematology

Cite this